Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbamoyl-phosphate synthetase 1 (CPS1) regulatory RNAs, including long non-coding RNAs (lncRNAs) like CPS1-IT1 and various microRNAs, are essential modulators of the CPS1 gene, which encodes the rate-limiting enzyme of the urea cycle (Summar et al., 2013). These regulatory molecules control the conversion of toxic ammonia into urea, thereby maintaining nitrogen homeostasis in the liver. The lncRNA CPS1-IT1 specifically acts as a tumor suppressor in hepatocellular carcinoma; its downregulation reduces CPS1 expression, leading to ammonia accumulation and accelerated tumor cell growth (Wang et al., 2014). Additionally, microRNAs such as miR-885-5p have been shown to post-transcriptionally repress CPS1, further influencing metabolic flux and disease progression (NCBI Gene). Dysregulation of these RNA networks is implicated in both urea cycle disorders and various cancers, making them attractive targets for precision medicine. While no specific drugs are currently approved to target these RNAs, experimental approaches using antisense oligonucleotides and miRNA mimics are under investigation to restore CPS1 function (Matsui & Corey, 2017). Targeting these regulatory RNAs provides a unique opportunity to address metabolic reprogramming in liver diseases and oncology.
Regulatory RNAs modulate CPS1 gene expression through various mechanisms: long non-coding RNAs like CPS1-IT1 can act as transcriptional activators or scaffolds for chromatin modifiers, while microRNAs like miR-885-5p typically bind to the 3' UTR of CPS1 mRNA to induce degradation or inhibit translation (Wang et al., 2014; NCBI Gene).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbamoyl-phosphate synthetase 1 regulatory RNA (CPS1-regRNA).